These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 7493603

  • 1. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors.
    Starr MS, Starr BS.
    Eur J Pharmacol; 1995 Apr 24; 277(2-3):151-8. PubMed ID: 7493603
    [Abstract] [Full Text] [Related]

  • 2. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
    Koshikawa N, Kitamura M, Kobayashi M, Cools AR.
    Eur J Pharmacol; 1996 Jul 25; 308(3):235-41. PubMed ID: 8858293
    [Abstract] [Full Text] [Related]

  • 3. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse.
    Starr BS, Starr MS, Kilpatrick IC.
    Neuroscience; 1987 Jul 25; 22(1):179-88. PubMed ID: 2957609
    [Abstract] [Full Text] [Related]

  • 4. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements.
    Koshikawa N, Miwa Y, Adachi K, Kobayashi M, Cools AR.
    Eur J Pharmacol; 1996 Jul 25; 308(3):227-34. PubMed ID: 8858292
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. D2 and D1 dopaminergic activity of 7-OH-DPAT.
    Sethy VH, Ellerbrock BR, Fici GJ, Wu H.
    Brain Res; 1996 Sep 09; 733(1):41-5. PubMed ID: 8891246
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice.
    Starr BS, Starr MS.
    Neuropharmacology; 1987 Jun 09; 26(6):613-9. PubMed ID: 2955244
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward.
    Ikemoto S, Glazier BS, Murphy JM, McBride WJ.
    J Neurosci; 1997 Nov 01; 17(21):8580-7. PubMed ID: 9334429
    [Abstract] [Full Text] [Related]

  • 17. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM.
    J Pharmacol Exp Ther; 1997 Oct 01; 283(1):7-15. PubMed ID: 9336302
    [Abstract] [Full Text] [Related]

  • 18. Selective attenuation of the antinociceptive effects of mu opioids by the putative dopamine D3 agonist 7-OH-DPAT.
    Cook CD, Rodefer JS, Picker MJ.
    Psychopharmacology (Berl); 1999 Jun 01; 144(3):239-47. PubMed ID: 10435390
    [Abstract] [Full Text] [Related]

  • 19. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
    Maj J, Rogóz Z, Skuza G, Kołodziejczyk K.
    Eur J Pharmacol; 1997 Apr 11; 324(1):31-7. PubMed ID: 9137910
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice.
    Starr MS, Starr BS.
    Psychopharmacology (Berl); 1994 Apr 11; 114(3):469-76. PubMed ID: 7855205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.